{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:27:29Z","timestamp":1783103249135,"version":"3.54.6"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2004,3,16]],"date-time":"2004-03-16T00:00:00Z","timestamp":1079395200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1038\/sj.bjc.6601736","type":"journal-article","created":{"date-parts":[[2004,4,14]],"date-time":"2004-04-14T11:59:19Z","timestamp":1081943959000},"page":"1516-1520","source":"Crossref","is-referenced-by-count":110,"title":["A Phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer"],"prefix":"10.1038","volume":"90","author":[{"given":"D C","family":"Doval","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J S","family":"Sekhon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S K","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Fuloria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V K","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B S","family":"Awasthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,3,16]]},"reference":[{"issue":"Suppl 6","key":"BF6601736_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0959-8049(01)80552-9","volume":"37","author":"T Andre","year":"2001","unstructured":"Andre T, Louvet C, Artru P, Selle F, Turnigand C, Garcia ML, Avenin D, Maindrault F, Provent S, DeGramont A (2001) A phase II study of gemcitabine and oxaliplatin (GEMOX) in advanced biliary adenocarcinoma (ABA). Preliminary results. Eur J Cancer 37, (Suppl 6) 19","journal-title":"Eur J Cancer"},{"key":"BF6601736_CR2","first-page":"A626","volume":"20","author":"G Arroyo","year":"2001","unstructured":"Arroyo G, Gallardo J, Rubio B, Orlandi L, Ya\u00f1ez M, Gamargo C, Ahumada M, Zarba J, Berlingeri G, Kowalyszyn R (2001) Gemcitabine (GEM) in advanced biliary tract cancer (ABTC). Experience from Chile and Argentina in phase II trials. Proc Am Soc Clin Oncol 20: A626 (abstract)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF6601736_CR3","first-page":"A2333","volume":"20","author":"S Carraro","year":"2001","unstructured":"Carraro S, Servienio PJ, Bruno MF, Castillo Odena MDS, Roca E, Jovtis S, Felci N, Araujo C (2001) Gemcitabine and cisplatin in locally advanced or metastatic gallbladder and bile duct adenocarcinomas. Proc Am Soc Clin Oncol 20: A2333 (abstract)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF6601736_CR4","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1056\/NEJM199910283411807","volume":"341","author":"PC De Groen","year":"1999","unstructured":"De Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM (1999) Biliary tract cancers. N Engl J Med 341: 1368\u20131378","journal-title":"N Engl J Med"},{"key":"BF6601736_CR5","first-page":"2476","volume":"95","author":"R Dobrila","year":"2000","unstructured":"Dobrila R, Kovac D, Depolo A, Dintinjana M (2000) Gemcitabine in patients with nonresectable cancer of the biliary system or advanced gallbladder cancer. Am J Gastroenterol 95: 2476 (abstract)","journal-title":"Am J Gastroenterol"},{"key":"BF6601736_CR6","first-page":"622","volume":"20","author":"DC Doval","year":"2001","unstructured":"Doval DC, Sekhon JS, Fuloria J, Gupta SK, Vaid AK, Gupta S, Shukla VK (2001) Gemcitabine and cisplatin in chemotherapy na\u00efve, unresectable gallbladder cancer: a large multicenter, phase II study. Proc Am Soc Clin Oncol 20: 622 (abstract)","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"Suppl 20","key":"BF6601736_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/sonc.2002.37375","volume":"29","author":"DC Doval","year":"2002","unstructured":"Doval DC, Sekhon JS, Gupta SK, Gupta S, Awasthy BS (2002) Chemotherapy in biliary tract carcinomas: results in India. Semin Oncol 29, (Suppl 20) 46\u201350","journal-title":"Semin Oncol"},{"key":"BF6601736_CR8","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1200\/JCO.2001.19.20.4089","volume":"19","author":"V Gebbia","year":"2001","unstructured":"Gebbia V, Giuliani F, Maiello E, Colucci G, Verderame F, Borsellino N, Mauceri G, Caruso M, Tirrito ML, Valdesi M (2001) Treatment of inoperable and\/or metastatic biliary tree carcinomas with single agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study. J Clin Oncol 19: 4089\u20134091","journal-title":"J Clin Oncol"},{"key":"BF6601736_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3322\/canjclin.51.1.15","volume":"51","author":"RT Greenlee","year":"2001","unstructured":"Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001) Cancer statistics. CA Cancer J Clin 51: 15\u201336","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"BF6601736_CR10","first-page":"117","volume":"27","author":"Y Hara","year":"2000","unstructured":"Hara Y, Kawasaki T, Yabata E, Gen T, Jibiki M, Kudoh A, Noguchi N, Kataoka T, Teramoto K, Iwai T (2000) A case of unresectable gallbladder cancer responding to combination therapy with hyperthermia and local chemotherapy. Gan to Kagaku Ryoho (Jpn J Cancer Chemother) 27(1): 117\u2013120","journal-title":"Gan to Kagaku Ryoho (Jpn J Cancer Chemother)"},{"issue":"27","key":"BF6601736_CR11","first-page":"1639","volume":"46","author":"H Hasegawa","year":"1999","unstructured":"Hasegawa H, Ueo H, Nanbara S, Tsuji K, Mori M, Akiyoshi T (1999) An effective pre-operative chemoimmunotherapy regimen against advanced gallbladder carcinoma: a case report. Hepato Gastroenterology 46(27): 1639\u20131642","journal-title":"Hepato Gastroenterology"},{"issue":"Suppl 5","key":"BF6601736_CR12","first-page":"196","volume":"13","author":"GV Kornek","year":"2002","unstructured":"Kornek GV, Schmid K, Schuell B (2002) Mitomycin C in combination with capecitabine or biweekly high dose gemcitabine in patients with advanced biliary tract cancer: preliminary results of a parallel phase II trial. Ann Oncol 13, (Suppl 5) 196 (abstract)","journal-title":"Ann Oncol"},{"issue":"Suppl 4","key":"BF6601736_CR13","doi-asserted-by":"publisher","first-page":"S151","DOI":"10.1016\/S0959-8049(99)80987-3","volume":"35","author":"S Kubicka","year":"1999","unstructured":"Kubicka S, Tietze MK, Rudolph L, Manns MP (1999) Phase II study of gemcitabine in patients with nonresectable cancer of the biliary system. Eur J Cancer 35, (Suppl 4) S151 (abstract)","journal-title":"Eur J Cancer"},{"key":"BF6601736_CR14","first-page":"A2272","volume":"20","author":"R Kuhn","year":"2001","unstructured":"Kuhn R, Ridwelski K, Eichelmann K, Rudolph S, Fahlke J, Ridwelski K (2001) Outpatient combination chemotherapy with gemcitabine and docetaxel in patients (Pts) with cancer of the biliary system. Proc Am Soc Clin Oncol 20: A2272","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"2","key":"BF6601736_CR15","first-page":"693","volume":"9","author":"D Makower","year":"2003","unstructured":"Makower D, Rozenblit A, Kaufman H, Edelman M, Lane ME, Zwiebel J, Haynes H, Wadler S (2003) Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies. Clinical Cancer Research 9(2: 693\u2013702","journal-title":"Clinical Cancer Research"},{"issue":"2","key":"BF6601736_CR16","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/00000421-200304000-00015","volume":"26","author":"IA Malik","year":"2003","unstructured":"Malik IA, Aziz Z, Zaidi SHM, Sethuraman G (2003) Gemcitabine and cisplatin is a highly effective combination chemotherapy in patients with advanced cancer of the gall bladder. Am J Clin Oncol (CCT) 26(2): 174\u2013177","journal-title":"Am J Clin Oncol (CCT)"},{"key":"BF6601736_CR17","first-page":"232","volume":"21","author":"J Metzger","year":"1998","unstructured":"Metzger J, Saurebruch T, Ko Y, Wolter H, Funk C, Glasmacher A (1998) A phase II trial of gemcitabine in gallbladder and biliary tract carcinomas. Onkologie 21: 232\u2013234","journal-title":"Onkologie"},{"issue":"Suppl 3","key":"BF6601736_CR18","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/(SICI)1097-0142(19960801)78:3<633::AID-CNCR44>3.0.CO;2-X","volume":"78","author":"M Moore","year":"1996","unstructured":"Moore M (1996) Activity of gemcitabine in patients with advanced pancreatic carcinoma: a review. Cancer 78, (Suppl 3) 633\u2013638","journal-title":"Cancer"},{"issue":"2","key":"BF6601736_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/00000421-200304000-00010","volume":"26","author":"AM Murad","year":"2003","unstructured":"Murad AM, Guimara RC, Aragao BC, Rodrigues VH, Scalabrini-Neto AO, Padua CA, Moore FC (2003) Phase II trial of the use of gemcitabine and 5-fluorouracil in the treatment of advanced pancreatic and biliary tract cancer. Am J Clin Oncol (CCT) 26(2): 151\u2013154","journal-title":"Am J Clin Oncol (CCT)"},{"issue":"9","key":"BF6601736_CR20","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s005950050253","volume":"28","author":"K Murakami","year":"1998","unstructured":"Murakami K, Tanimura H, Yamaue H, Mizobata S, Noguchi K, Nakamori M, Shimamoto T (1998) Clinical effect of immunochemotherapy for a patient with advanced gallbladder cancer: report of a case. Surgery Today 28(9): 923\u2013928","journal-title":"Surgery Today"},{"key":"BF6601736_CR21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1023\/A:1008352123009","volume":"12","author":"M Penz","year":"2001","unstructured":"Penz M, Kornek GV, Raderer M, Ulrich-Pur H, Fiebiger W, Lenauer A, Depisch D, Krauss G, Schneeweiss B, Scheithauer W (2001) Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer. Ann Oncol 12: 183\u2013186","journal-title":"Ann Oncol"},{"issue":"4 Suppl 11","key":"BF6601736_CR22","first-page":"72","volume":"22","author":"GJ Peters","year":"1995","unstructured":"Peters GJ, Bergman AM, Ruiz van Haperen VW, Veerman G, Kuiper CM, Braakhuis BJ (1995) Interaction between cisplatin and gemcitabine in vitro and in vivo. Semin Oncol 22, (4 Suppl 11) 72\u201379","journal-title":"Semin Oncol"},{"issue":"6 Suppl 20","key":"BF6601736_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1053\/sonc.2002.37380","volume":"29","author":"W Scheithauer","year":"2002","unstructured":"Scheithauer W (2002) Review of gemcitabine in biliary tract carcinoma. Semin Oncol 29, (6 Suppl 20) 40\u201345","journal-title":"Semin Oncol"},{"issue":"8","key":"BF6601736_CR24","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1002\/cncr.10831","volume":"95","author":"T Takada","year":"2002","unstructured":"Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, Nagakawa T, Nakayama T (2002) Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 95(8): 1685\u20131695","journal-title":"Cancer"},{"key":"BF6601736_CR25","first-page":"498","volume":"22","author":"J Valencak","year":"1999","unstructured":"Valencak J, Kornek GV, Raderer M, Ulrich-Pur H, Krauss G, Greul R, Pidlich J, Pfeffel F, Haider K, Kwasny W, Schneeweiss B, Scheithauer W (1999) Gemcitabine for the treatment of advanced biliary tract carcinomas: evaluation of two different dose regimens. Onkologie 22: 498\u2013501","journal-title":"Onkologie"},{"key":"BF6601736_CR26","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/00001813-200010000-00006","volume":"11","author":"F Verderame","year":"2000","unstructured":"Verderame F, Mandina P, Abruzzo F, Scarpulla M, Di Leo R (2000) Biliary tract cancer: our experience with gemcitabine treatment. Anti-Cancer Drugs 11: 707\u2013708","journal-title":"Anti-Cancer Drugs"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6601736.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601736","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601736.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:57:00Z","timestamp":1684414620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6601736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,16]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["BF6601736"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6601736","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,16]]}}}